Price Momentum and Recent Market Performance
Suven Life Sciences closed at ₹268.15 on 22 Jun 2026, up from the previous close of ₹259.70, marking a daily increase of 3.25%. The stock traded within a range of ₹254.55 to ₹271.35 during the day, inching closer to its 52-week high of ₹303.00, while comfortably above its 52-week low of ₹124.35. This price action reflects a strong recovery and sustained buying interest in the stock.
When compared to the broader market, Suven Life Sciences has outperformed significantly over longer time horizons. Year-to-date, the stock has surged 60.71%, while the Sensex has declined by 9.88%. Over one year, the stock gained 18.31% against the Sensex’s 5.60% loss. The three-year and five-year returns are even more impressive, with Suven Life Sciences delivering 323.62% and 190.21% respectively, dwarfing the Sensex’s 21.58% and 46.73% gains. Over a decade, the stock’s return of 1,758.22% vastly outpaces the Sensex’s 188.45%, underscoring its long-term growth trajectory.
Technical Indicator Analysis: Mixed Signals
The technical landscape for Suven Life Sciences is characterised by a blend of bullish and bearish signals across different timeframes and indicators, reflecting a complex momentum environment.
MACD (Moving Average Convergence Divergence): Both weekly and monthly MACD indicators are bullish, signalling positive momentum and suggesting that the stock’s upward trend is supported by strong buying pressure. This is a key indicator favoured by technical analysts to confirm trend direction and momentum strength.
RSI (Relative Strength Index): The weekly RSI currently shows no clear signal, indicating a neutral momentum in the short term. However, the monthly RSI is bearish, suggesting that on a longer timeframe, the stock may be approaching overbought conditions or facing selling pressure. This divergence between weekly and monthly RSI warrants caution for investors looking for sustained momentum.
Bollinger Bands: On a weekly basis, Bollinger Bands are bullish, indicating that the stock price is trending near the upper band, which often signals strength and potential continuation of the uptrend. The monthly Bollinger Bands are mildly bullish, reflecting a more tempered but still positive outlook over the longer term.
Moving Averages: Daily moving averages are bullish, reinforcing the short-term upward momentum. This suggests that recent price action is supported by strong technical buying and that the stock is trading above key moving average levels.
KST (Know Sure Thing): The weekly KST indicator is bullish, aligning with the positive momentum seen in other short-term indicators. Conversely, the monthly KST is mildly bearish, indicating some weakening momentum on a longer horizon.
Dow Theory: Weekly Dow Theory signals are mildly bearish, hinting at some short-term caution, while monthly signals are mildly bullish, suggesting that the broader trend remains positive. This mixed reading highlights the importance of monitoring price action closely in the coming weeks.
OBV (On-Balance Volume): Weekly OBV is mildly bearish, indicating that volume trends may not fully support the recent price gains in the short term. However, monthly OBV is bullish, suggesting accumulation over the longer term and underlying institutional interest.
Our current Stock of the Month is out! This Large Cap from Automobiles - Passenger Cars emerged as the single best opportunity from our elite universe. Get the details now!
- - Current monthly selection
- - Single best opportunity
- - Elite universe pick
Mojo Score and Grade Update
Suven Life Sciences currently holds a Mojo Score of 40.0, which places it in the 'Sell' category. This represents an improvement from its previous 'Strong Sell' grade, which was updated on 18 May 2026. The upgrade in grade reflects the recent positive shifts in technical momentum and price action, although the score remains on the lower side, signalling caution for investors. The company is classified as a small-cap within the Healthcare Services sector, which typically entails higher volatility and risk compared to larger peers.
Technical Trend Shift: From Mildly Bullish to Bullish
The overall technical trend for Suven Life Sciences has shifted from mildly bullish to bullish, indicating a strengthening of upward momentum. This shift is supported by the alignment of several key indicators such as the MACD, daily moving averages, and weekly Bollinger Bands. However, the presence of bearish signals in monthly RSI and KST, as well as mildly bearish weekly Dow Theory and OBV, suggests that the stock may face intermittent resistance or profit-taking in the near term.
Investors should note that while the short-term technicals are encouraging, the mixed signals on longer timeframes warrant a cautious approach. Monitoring volume trends and momentum oscillators will be crucial to confirm the sustainability of the current rally.
Comparative Performance and Sector Context
Within the Healthcare Services sector, Suven Life Sciences’ recent performance stands out, especially when benchmarked against the Sensex. The stock’s robust returns over multiple periods highlight its potential as a growth-oriented investment, albeit with elevated risk typical of small-cap stocks. The sector itself has been under pressure recently, making Suven’s relative strength notable.
Holding Suven Life Sciences Ltd from Healthcare Services? See if there's a smarter choice! SwitchER compares it with peers and suggests superior options across market caps and sectors!
- - Peer comparison ready
- - Superior options identified
- - Cross market-cap analysis
Investor Takeaway and Outlook
Suven Life Sciences’ recent technical upgrades and price momentum suggest a positive near-term outlook, supported by bullish MACD readings and daily moving averages. However, the mixed signals from monthly RSI and KST, alongside mildly bearish volume indicators, imply that investors should remain vigilant for potential pullbacks or consolidation phases.
Given the stock’s small-cap status and sector dynamics, it is best suited for investors with a higher risk tolerance who can capitalise on its growth potential while managing volatility. The upgrade from 'Strong Sell' to 'Sell' Mojo Grade indicates improving fundamentals and technicals, but the score of 40.0 still advises caution.
In summary, Suven Life Sciences is exhibiting signs of strengthening momentum, but the presence of conflicting technical signals across timeframes calls for a balanced approach. Investors should monitor key support and resistance levels, volume trends, and broader market conditions to make informed decisions.
Summary of Key Technical Indicators:
- MACD: Weekly and Monthly - Bullish
- RSI: Weekly - Neutral; Monthly - Bearish
- Bollinger Bands: Weekly - Bullish; Monthly - Mildly Bullish
- Moving Averages (Daily): Bullish
- KST: Weekly - Bullish; Monthly - Mildly Bearish
- Dow Theory: Weekly - Mildly Bearish; Monthly - Mildly Bullish
- OBV: Weekly - Mildly Bearish; Monthly - Bullish
Investors should weigh these indicators collectively rather than in isolation to gauge the stock’s true momentum and potential trajectory.
Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →
